FDA provides flexibility for pharmacies’ PPE use amid COVID-19 shortages

The Food and Drug Administration today issued temporary guidance for pharmacies’ preservation of limited supplies of personal protective equipment. As part of this policy, FDA is providing “limited regulatory flexibility for compounders that cannot obtain sufficient supplies of PPE for sterile compounding, provided they adopt risk mitigation strategies.”